R Larsson

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients.

M O Karlsson, J. Bergh, M. Karlsson, 2003, European journal of cancer.

Overview of the clinical efficacy of investigational anticancer drugs

R. Larsson, P. Nygren, R Larsson, 2003, Journal of internal medicine.

Pharmacokinetic models for the saturable distribution of paclitaxel.

M O Karlsson, J. Bergh, M. Karlsson, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

M. Höglund, M. Jarvius, A. Österroos, 2015, Blood Cancer Journal.

CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.

T. Skov, L. Binderup, R. Larsson, 1999, Cancer research.

Apoptosis induced by calcein acetoxymethyl ester in the human histiocytic lymphoma cell line U-937 GTB.

B. Jonsson, R. Larsson, P. Nygren, 2000, Biochemical pharmacology.

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

A. Isaksson, M. Gustafsson, R. Larsson, 2005, British Journal of Cancer.

Microphysiometry: new technology for evaluation of anticancer drug activity in human tumor cells in vitro

R. Larsson, P. Nygren, R Larsson, 1998, Anti-cancer drugs.